A review of the research progress of miR-1237 in malignant tumors

Area of Science:

• Molecular Biology
• Oncology
• Biochemistry

Background:

• MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression.
• MiR-1237 has emerged as a significant factor in the development and progression of various malignant tumors.
• Understanding miR-1237's role is crucial for advancing cancer research and treatment.

Purpose of the Study:

• To systematically review the expression patterns and functional mechanisms of miR-1237 in different types of cancer.
• To explore the potential of miR-1237 as a biomarker for cancer diagnosis, prognosis, and therapeutic targeting.
• To discuss the implications of miR-1237 in precision medicine and future cancer therapy development.

Main Methods:

• Literature review and systematic analysis of existing research on miR-1237 in malignant tumors.
• Compilation of data on miR-1237 expression levels and their correlation with clinical and pathological features.
• Analysis of cellular and molecular mechanisms underlying miR-1237's function in cancer biology.

Main Results:

• MiR-1237 exhibits altered expression in various cancers, correlating with clinical outcomes.
• MiR-1237 influences key cellular processes involved in tumor occurrence, development, and treatment response.
• Evidence suggests miR-1237's involvement in tumor suppression or oncogenesis depending on the cancer type.

Conclusions:

• MiR-1237 holds significant potential as a diagnostic and prognostic biomarker in oncology.
• Targeting miR-1237 may offer novel therapeutic strategies for personalized cancer treatment.
• Further research is warranted to fully elucidate miR-1237's clinical utility in precision oncology.